Hongchen Qiu

Statistics

Publications

Citations

540

H-Index

Active since

2002

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Bristol-Myers Squibb (United States)

Albany Molecular Research (United States)

Zhengzhou University

United States Pharmacopeial Convention

Hongchen Qiu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2002–2025

Publications

The effect of cadmium on the growth and antioxidant response for freshwater algae Chlorella vulgaris

Jinfeng Cheng, Hongchen Qiu, Zhaoyang Chang et al. · SpringerPlus · 2016 · 173 citations · Full text

Life Sciences, Biochemistry, Plant Sciences +17

Pharmacological Characterization of Sch527123, a Potent Allosteric CXCR1/CXCR2 Antagonist

Waldemar Gonsiorek, Xuedong Fan, David Hesk et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 130 citations

Life Sciences, Immunology, Pharmacology +17

Identification of full, partial and inverse CC chemokine receptor 3 agonists using [35S]GTPγS binding

Yuntao Wan, James Jakway, Hongchen Qiu et al. · European Journal of Pharmacology · 2002 · 32 citations

Medicine, Medicinal Chemistry, Pharmacology +12

DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell–mediated antitumor immunity

Michael Wichroski, Joseph L. Benci, Si-Qi Liu et al. · Science Translational Medicine · 2023 · 29 citations

Life Sciences, Immunology, Medicinal Chemistry +17

3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists

Purakkattle Biju, Arthur G. Taveras, Younong Yu et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 24 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

1–5 of 14